fbpx
TRT Blog

Harvard Medical Professor, Testosterone can reduce Cardiovascular risk factors

Testosterone Links Cardiovascular Risk

Previous studies on the link between heart attack and testosterone therapy have come under scrutiny lately by several groups. The most recent being Dr. Abraham Morgentaler, an Associate Clinical Professor of Urology at Harvard Medical School and affiliated with Beth Israel Deaconess Medical Center, in Boston, MA.

He discusses the flawed study that pointed to the risk of heart attacks with testosterone therapy and discusses how in fact testosterone therapy can indeed reduce risk factors for heart disease.

Dr. Abraham Morgentaler, an Associate Clinical Professor of Urology at Harvard Medical School and affiliated with Beth Israel Deaconess Medical Center, in Boston, MA, along with his coauthors, explore and clarify in the February 2015 issue of Mayo Clinic Proceedings, the value of testosterone therapy in men, and in particular the issue of cardiovascular risk.

Testosterone Therapy properly managed can decrease risk factors for heart attacks in men.  He discusses the flawed study that was published:

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About Mantality Direct

Mantality Direct introduces overall wellness to men’s lives by performing testosterone replacement therapy on men who qualify all in the comfort of your home.

Read More

Our Mission

Helping men live more powerful lives.

Our Vision

Give men back the drive to compete and win in their lives for themselves, their families, and their communities.

Subscribe to Our Blog

Mantality Edge

Cutting-edge products for the every day working man

Scroll to Top

This website uses cookies to ensure you get the best experience on our website.